Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Two-part Phase IIa Randomised, Double-blind, Placebo-controlled, Dose ranging, Multi centre Study to Assess Efficacy and Safety of Inhaled AZD1402 Administered as a Dry Powder Twice Daily for Four Weeks in Adults with Asthma on Medium-to-High Dose Inhaled Corticosteroids

Next Previous
X
Search
Trial Profile

A Two-part Phase IIa Randomised, Double-blind, Placebo-controlled, Dose ranging, Multi centre Study to Assess Efficacy and Safety of Inhaled AZD1402 Administered as a Dry Powder Twice Daily for Four Weeks in Adults with Asthma on Medium-to-High Dose Inhaled Corticosteroids

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Feb 2025

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Elarekibep (Primary) ; Adrenergic agents; Corticosteroids; Salbutamol
  • Indications Asthma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms APATURA
  • Sponsors AstraZeneca; AstraZeneca AB

    • Most Recent Events

    • 14 Aug 2023 Status changed from active, no longer recruiting to discontinued.
    • 28 Jul 2023 This trial has been Suspended in Spain, according to European Clinical Trials Database record.
    • 20 Jul 2023 Planned End Date changed from 26 Feb 2024 to 19 Jul 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top